{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:29:02Z","timestamp":1791228542558,"version":"4.1.0"},"reference-count":41,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T00:00:00Z","timestamp":1560124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009687","name":"Uniwersytet Medyczny im. Piast\u00f3w Slaskich we Wroclawiu","doi-asserted-by":"publisher","award":["#ST-878"],"award-info":[{"award-number":["#ST-878"]}],"id":[{"id":"10.13039\/501100009687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and objectives: Interleukin-7 (IL-7) is exploited in cancer immunotherapies although its status in solid tumors is largely unknown. We aimed to determine its systemic and local concentrations in esophageal (EC), gastric (GC), and colorectal (CRC) cancers. Materials and Methods: IL-7 was immunoenzymatically measured in paired surgical specimens of tumors and tumor-adjacent tissue (n = 48), and in the sera of 170 individuals (54 controls and 116 cancer patients). Results: IL-7 was higher in tumors as compared to noncancerous tissue in all cancers (mean difference: 29.5 pg\/g). The expression ratio (tumor to normal) was 4.4-fold in GC, 2.2-fold in EC, and 1.7-fold in CRC. However, when absolute concentrations were compared, the highest IL-7 concentrations were in CRC, both when tumor and noncancerous tissue were analyzed. In CRC tumors, IL-7 was 2 and 1.5 times higher than in EC and GC tumors. In noncancerous CRC tissue, IL-7 was 2.3- and 2.8-fold higher than in EC and GC. IL-7 overexpression was more pronounced in Stage 3\/4 and N1 cancers as a result of decreased cytokine expression in noncancerous tissue. Tumor location was a key factor in determining both local and systemic IL-7 concentrations. Serum IL-7 in CRC and EC was higher than in controls, GC, and patients with adenocarcinoma of gastric cardia (CC), but no significant correlation with the disease advancement could be observed. Conclusions: IL-7 protein is overexpressed in EC, GC, and CRC, but concentrations differ both in tumor and tumor-adjacent tissue with respect to tumor location. More advanced cancers have lower IL-7 concentrations in the immediate environment of the tumor. At the systemic level, IL-7 is elevated in CRC and EC, but not CC or GC. IL-7 dependence on the location of the primary tumor should be taken into account in future IL-7-based immunotherapies. Functional studies explaining a role of IL-7 in gastrointestinal cancers are needed.<\/jats:p>","DOI":"10.3390\/medicina55060262","type":"journal-article","created":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T11:39:47Z","timestamp":1560166787000},"page":"262","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Local and Systemic IL-7 Concentration in Gastrointestinal-Tract Cancers"],"prefix":"10.3390","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7244-2017","authenticated-orcid":false,"given":"Iwona","family":"Bednarz-Misa","sequence":"first","affiliation":[{"name":"Department of Medical Biochemistry, Wroclaw Medical University, 50-368 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1377-5601","authenticated-orcid":false,"given":"Dorota","family":"Diakowska","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal and General Surgery, Wroclaw Medical University, 50-368 Wroclaw, Poland"},{"name":"Department of Nervous System Diseases, Wroclaw Medical University, 51-618 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2753-8092","authenticated-orcid":false,"given":"Ma\u0142gorzata","family":"Krzystek-Korpacka","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Wroclaw Medical University, 50-368 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,6,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"474","DOI":"10.21037\/jgo.2017.05.01","article-title":"Immunotherapy in gastrointestinal cancers","volume":"8","author":"Grierson","year":"2017","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.6004\/jnccn.2017.0037","article-title":"An expanding role for immunotherapy in colorectal cancer","volume":"15","author":"Bever","year":"2017","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc1252","article-title":"Cytokines in cancer pathogenesis and cancer therapy","volume":"4","author":"Dranoff","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1089\/jir.2018.0019","article-title":"Cytokines in the treatment of cancer","volume":"39","author":"Conlon","year":"2019","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1158\/1078-0432.CCR-09-1303","article-title":"Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy","volume":"16","author":"Babb","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11523-012-0210-4","article-title":"Interleukin-7 and immune reconstitution in cancer patients: a new paradigm for dramatically increasing overall survival","volume":"7","author":"Morre","year":"2012","journal-title":"Target Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.cji.0000210386.55951.c2","article-title":"IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells","volume":"29","author":"Rosenberg","year":"2006","journal-title":"J. Immunother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"10267","DOI":"10.3390\/ijms160510267","article-title":"Mechanism of action of IL-7 and its potential applications and limitations in cancer immunotherapy","volume":"16","author":"Gao","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"ref_10","first-page":"911","article-title":"Interleukin-7 (IL-7) and IL-7 receptor (IL-7R) signalling complex in human solid tumours","volume":"18","author":"Mansel","year":"2003","journal-title":"Histol. Histopathol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Mengus, C., le Magnen, C., Trella, E., Yousef, K., Bubendorf, L., Provenzano, M., and Provenzano, S. (2011). Elevated levels of circulating IL-7 and IL-15 in patients with early stage prostate cancer. J. Transl. Med., 9.","DOI":"10.1186\/1479-5876-9-162"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Roato, I., Caldo, D., Godio, L., D\u2019Amico, L., Giannoni, P., Morello, E., and Ferracini, R. (2010). Bone invading NSCLC cells produce IL-7: mice model and human histologic data. BMC Cancer, 10.","DOI":"10.1186\/1471-2407-10-12"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1365-2273.2001.00475.x","article-title":"Interleukins 7 and 12 are expressed in head and neck squamous cancer","volume":"26","author":"Paleri","year":"2001","journal-title":"Clin. Otolaryngol. Allied Sci."},{"key":"ref_14","first-page":"395","article-title":"Oncogenic IL7R is downregulated by histone deacetylase inhibitor in esophageal squamous cell carcinoma via modulation of acetylated FOXO1","volume":"53","author":"Kim","year":"2018","journal-title":"Int. J. Oncol."},{"key":"ref_15","first-page":"43","article-title":"Peripheral blood immunological parameters for use as markers of pre-invasive to invasive colorectal cancer","volume":"17","author":"Berghella","year":"2002","journal-title":"Cancer Biother. Radiopharm."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/15384047.2015.1026476","article-title":"Laparoscopic surgery for colorectal cancer is not associated with an increase in the circulating levels of several inflammation-related factors","volume":"16","author":"Crucitti","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/cas.12663","article-title":"Inflammatory features of pancreatic cancer highlighted by monocytes\/macrophages and CD4+ T cells with clinical impact","volume":"106","author":"Komura","year":"2015","journal-title":"Cancer Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00011-014-0739-z","article-title":"Interleukins as markers of inflammation in malignant and benign thyroid disease","volume":"63","author":"Provatopoulou","year":"2014","journal-title":"Inflamm. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/ijc.29017","article-title":"A prognostic classifier consisting of 17 circulating cytokines is a novel predictor of overall survival for metastatic colorectal cancer patients","volume":"136","author":"Chen","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1158\/1078-0432.CCR-06-1828","article-title":"Serum cytokine profiling as a diagnostic and prognostic tool in ovarian cancer: A potential role for interleukin 7","volume":"13","author":"Lambeck","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00262-016-1933-3","article-title":"Elevated systemic interleukin-7 in patients with colorectal cancer and individuals at high risk of cancer: association with lymph node involvement and tumor location in the right colon","volume":"66","author":"Zawadzki","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1200\/JCO.2018.36.5_suppl.101","article-title":"Effect of andecaliximab (anti-MMP9) on proteolysis of IL-7 in vitro, TCR diversity in mice, and serum IL-7 in gastric cancer patients in combination with chemotherapy","volume":"36","author":"Greenstein","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"963","DOI":"10.21873\/anticanres.11405","article-title":"The role of IL-7 in immunity and cancer","volume":"37","author":"Lin","year":"2017","journal-title":"Anticancer Res."},{"key":"ref_24","unstructured":"Krzystek-Korpacka, M., Zawadzki, M., Szufnarowski, K., Bednarz-Misa, I., Gorska, S., Witkiewicz, W., and Gamian, A. (2018). The perioperative dynamics of IL-7 following robot-assisted and open colorectal surgery. Sci. Rep., 8."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.smim.2012.02.005","article-title":"IL-7 in human health and disease","volume":"24","author":"Fewkes","year":"2012","journal-title":"Semin. Immunol"},{"key":"ref_26","unstructured":"Sobin, L.H., Gospodarowicz, M.K., and Wittekind, C. (2010). TNM Classification of Malignant Tumours, UICC. [7th ed.]."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1128\/IAI.00320-15","article-title":"Interleukin-7 produced by intestinal epithelial cells in response to Citrobacter rodentium infection plays a major role in innate immunity against this pathogen","volume":"83","author":"Zhang","year":"2015","journal-title":"Infect. Immun."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/mc.22082","article-title":"Antilymphangiogenesis effects of a specific antiinterleukin 7 receptor antibody in lung cancer model in vivo","volume":"54","author":"Ming","year":"2015","journal-title":"Mol. Carcinog."},{"key":"ref_29","first-page":"870","article-title":"Interleukin 7 signaling prevents apoptosis by regulating bcl-2 and bax via the p53 pathway in human non-small cell lung cancer cells","volume":"7","author":"Liu","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/bjs.4832","article-title":"Interleukin 7 upregulates vascular endothelial growth factor D in breast cancer cells and induces lymphangiogenesis in vivo","volume":"92","author":"Watkins","year":"2005","journal-title":"Br. J. Surg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1046\/j.1365-3083.1997.d01-384.x","article-title":"Interleukin-7 (IL-7) in colorectal cancer: IL-7 is produced by tissues from colorectal cancer and promotes preferential expansion of tumour infiltrating lymphocytes","volume":"45","author":"Maeurer","year":"1997","journal-title":"Scand. J. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1172\/JCI116785","article-title":"Antitumor effects of interleukin-7 and adoptive immunotherapy on human colon carcinoma xenografts","volume":"92","author":"Murphy","year":"1993","journal-title":"J. Clin. Investig."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Gou, H.F., Huang, J., Shi, H.S., Chen, X.C., and Wang, Y.S. (2014). Chemo-immunotherapy with oxaliplatin and interleukin-7 inhibits colon cancer metastasis in mice. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0085789"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3892\/etm.2016.3263","article-title":"Potential implications of interleukin-7 in chronic wound healing","volume":"12","author":"Bartlett","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Shi, L.Z., Fu, T., Guan, B., Chen, J., Blando, J.M., Allison, J.P., Xiong, L., Subudhi, S.K., Gao, J., and Sharma, P. (2016). Interdependent IL-7 and IFN-\u03b3 signalling in T-cell controls tumour eradication by combined \u03b1-CTLA-4+\u03b1-PD-1 therapy. Nat. Commun., 7.","DOI":"10.1038\/ncomms12335"},{"key":"ref_36","first-page":"7360","article-title":"Expression profile of cytokines in gastric cancer patients using proteomic antibody microarray","volume":"14","author":"Quan","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1053\/gast.1996.v110.pm8964399","article-title":"Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa","volume":"110","author":"Yamaoka","year":"1996","journal-title":"Gastroenterology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1089\/jir.1995.15.1005","article-title":"Cytokine mRNA expression patterns in human esophageal cancer cell lines","volume":"15","author":"Oka","year":"1995","journal-title":"J. Interferon. Cytokine Res."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Huang, H. (2018). Matrix metalloproteinase-9 (MMP-9) as a cancer biomarker and MMP-9 biosensors: recent advances. Sensors, 18.","DOI":"10.3390\/s18103249"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/infdis\/jiu125","article-title":"Inflammatory cytokines drive CD4+ T-cell cycling and impaired responsiveness to interleukin 7: implications for immune failure in HIV disease","volume":"210","author":"Shive","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/carcin\/bgv123","article-title":"Immunosuppression associated with chronic inflammation in the tumor microenvironment","volume":"36","author":"Wang","year":"2015","journal-title":"Carcinogenesis"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/55\/6\/262\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:57:17Z","timestamp":1760187437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/55\/6\/262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,10]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6]]}},"alternative-id":["medicina55060262"],"URL":"https:\/\/doi.org\/10.3390\/medicina55060262","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,10]]}}}